scholarly journals ANALYSIS OF EFFICIENCY OF DIFFERENT METHODS OF TREATMENT OF PATIENTS WITH ACUTE THROMBOSIS IN THE INFERIOR VENA CAVA

2020 ◽  
pp. 26-30
Author(s):  
V. A. Prasol ◽  
D. V. Oklei ◽  
I. A. Taraban

Summary. Research aim. To estimate efficiency of thromboclasis and anticoagulating therapy for patients with DVT of pelvis and lower limbs and to determine the severity of CVI caused by PTD in the long term. Material and methods. 138 patients with thrombosis in the system of the inferior vena cava were examined and treated. Results and discussion. Thrombolytic therapy (TLT) as a basic method of treatment was used in 52 (37.7 %) patients. 20 (14.5 %) patients undergone catheter-controlled thrombolysis(CCT) and 32 (23.2 %) patients had systemic thrombolytic therapy. 86 (62.3 %) patients in the basic treatment had anticoagulant therapy (ACT). In the long-term results of TLT significantly exceed the results of ACT. 70 % of these patients had signs of postthrombotic disease (PTD) with mild chronic venous insufficiency(CVI), and 100 % of patients with ACT had more severe forms of PTD. Conclusions. Application of TLT for patients from with DVT of the pelvis and lower limbs resulted in rapid regress or complete removal of basic clinical signs of venous thrombosis. Instrumental methods of research, such as Doppler ultrasonography and color duplex scanning, as well as X-ray contrast phlebography are the only informative methods for assessing the process of dissolution of blood clots, the functional state of deep veins of the pelvis and lower limbs during CCT.

1992 ◽  
Vol 26 (6) ◽  
pp. 480-486 ◽  
Author(s):  
David Rosenthal ◽  
John C. Hungerpiller ◽  
Mary Annette Seagraves ◽  
Luke S. Erdoes ◽  
David R. Baird ◽  
...  

1998 ◽  
Vol 8 (2) ◽  
pp. 289-294 ◽  
Author(s):  
P. A. Poletti ◽  
C. D. Becker ◽  
L. Prina ◽  
P. Ruijs ◽  
H. Bounameaux ◽  
...  

2020 ◽  
Author(s):  
Xianwei Yang ◽  
Tao Wang ◽  
Junjie Kong ◽  
Bin Huang ◽  
Wentao Wang

Abstract Background: Retrohepatic inferior vena cava (RIVC) resection without reconstruction in ex vivo liver resection and autotransplantation (ERAT) for advanced alveolar echinococcosis (HAE) is unclear. Methods: This is a retrospective study of consecutive patients referred to our hospital from 2014 to 2018. Depending on the presence of a rich collateral circulation and stable blood volume in ERAT, patients did not rebuild the RIVC. Then, patients were selected some appropriate revascularization techniques for the hepatic and renal veins. Finally, all ERAT procedures were completed, and short- and long-term outcomes were observed. Results: Five advanced HAE patients underwent ERAT without RIVC reconstruction. One patient died of circulatory failure 1 day after surgery. Another four patients, with a median follow-up duration of 18 months (range, 10-25 months), demonstrated normal liver and kidney function, no thrombosis and no HAE recurrence. Conclusions: Through the long-term results of ERAT, the pros and cons of not reconstructing the RIVC need to be re-examined. In cases with a rich collateral circulation, the RIVC cannot be reconstructed. However, in cases requiring the resection of multiple organs, RIVC without reconstruction was prudential.


2017 ◽  
Vol 13 (1) ◽  
pp. 37-44 ◽  
Author(s):  
V. A. Atduev ◽  
Z. V. Amoev ◽  
A. A. Danilov ◽  
V. A. Bel’skiy ◽  
D. S. Ledyaev ◽  
...  

1988 ◽  
Vol 60 (03) ◽  
pp. 495-497 ◽  
Author(s):  
Akira Shibuya ◽  
Haruhiko Ninomiya ◽  
Masaki Nakazawa ◽  
Toshiro Nagasawa ◽  
Yasuhiro Yoda ◽  
...  

SummaryThree patients with familial antithrombin III (ATIII) deficiency, who also have histories of thromboembolism, were treated with oxymetholone in combination with warfarin. Thrombolysis was observed in one patient with acute thrombosis of inferior vena cava during the oxymetholone and warfarin therapy. No further thromboembolic episodes occurred in these patients after initiation of warfarin with or without oxymetholone. The levels of plasma ATIII, α1-antitrypsin, plasminogen and Cl-inactivator were significantly increased in all patients after the introduction of oxymetholone therapy. This suggests that oxymetholone augments anticoagulant and fibrinolytic activity. Hence we consider that oxymetholone in combination with warfarin may be possible thrombolytic therapy in patients with familial ATIII deficiency.


2000 ◽  
Vol 39 (9) ◽  
pp. 707-714 ◽  
Author(s):  
Takahiro YAZU ◽  
Hirofumi FUJIOKA ◽  
Mashio NAKAMURA ◽  
Naoto HIRAOKA ◽  
Norikazu YAMADA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document